|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue from Contract with Customer, Including Assessed Tax | |||||
| Product | |||||
| Service | |||||
| Total revenue from Contract with Customer, Including Assessed Tax | |||||
| Cost of revenue | |||||
| Cost of Goods and Services Sold | |||||
| Product | |||||
| Service | |||||
| Total cost of Goods and Services Sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative expenses | |||||
| Research and development | |||||
| Impairment expense | |||||
| Credit Loss Expense | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| PPP forgiveness | |||||
| Finance fee | |||||
| Tax credit expense | |||||
| Total other income | |||||
| Grant income | |||||
| Interest income | |||||
| Interest expense | |||||
| Total other expense | |||||
| Net loss | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
| Comprehensive loss attributable to noncontrolling interest | |||||
| Comprehensive loss attributable to stockholders | |||||
| Net loss attributable to noncontrolling interest | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per share attributable to common stockholders: | |||||
| Loss per share attributable to stockholders – basic and diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: (in shares) | |||||
Loading...